Literature DB >> 9833750

Gender and survival after AIDS in Rio de Janeiro, Brazil.

G Santoro-Lopes1, L H Harrison, L H Moulton, L A Lima, A M de Pinho, C Hofer, M Schechter.   

Abstract

The relation between gender and survival after a diagnosis of AIDS was studied in a cohort of patients with HIV infection in Rio de Janeiro, Brazil. During the study period, 124 of 617 patients (20%) developed AIDS. Of this group, 91 patients were men and 33 were women. There were no gender related differences regarding the access to antiretroviral therapy or to prophylaxis for Pneumocystis carinii pneumonia. Survival was shorter among women (hazard ratio [HR] = 4.43; p < .001) after adjustment for age and AIDS-defining condition. Adjusting for CD4+ and CD8+ counts reduced the difference between genders (HR = 3.33; p = .017). These results suggest that survival after an AIDS diagnosis may be shorter among women than men in Brazil. Further studies are needed to determine the factors that may be negatively influencing the prognosis of women with AIDS in Brazil.

Entities:  

Keywords:  Acquired Immunodeficiency Syndrome--women; Americas; Brazil; Comparative Studies; Demographic Factors; Developing Countries; Diseases; Gender Issues; Hiv Infections--women; Latin America; Mortality; Population; Population Dynamics; Research Methodology; Research Report; South America; Studies; Time Factors; Viral Diseases

Mesh:

Substances:

Year:  1998        PMID: 9833750     DOI: 10.1097/00042560-199812010-00012

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


  2 in total

1.  Gender-related mortality for HIV-infected patients on highly active antiretroviral therapy (HAART) in rural Uganda.

Authors:  Arif Alibhai; Walter Kipp; L Duncan Saunders; Ambikaipakan Senthilselvan; Amy Kaler; Stan Houston; Joseph Konde-Lule; Joa Okech-Ojony; Tom Rubaale
Journal:  Int J Womens Health       Date:  2010-08-09

2.  Survival benefits of antiretroviral therapy in Brazil: a model-based analysis.

Authors:  Paula M Luz; Michael P Girouard; Beatriz Grinsztejn; Kenneth A Freedberg; Valdilea G Veloso; Elena Losina; Claudio J Struchiner; Rachel L MacLean; Robert A Parker; A David Paltiel; Rochelle P Walensky
Journal:  J Int AIDS Soc       Date:  2016-03-29       Impact factor: 5.396

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.